August 2023

Contents

Editorial

• HTB July/August 2023

• Non technical HTB: 11 stories from July/August

Conference reports

• 12th IAS Conference on HIV Science (IAS 2023)

• IAS 2023: Update to navigate the programme and online access

• WHO endorses “zero” transmission risk for people with HIV with an undetectable viral load

• Viral load level when suppressed <1000 predicts future rebound: 3-monthly monitoring required

• ART-associated hypertension can be successfully treated in African settings

• REPRIEVE study: statin benefits people living with HIV at low to moderate CVD risk

• Geneva patient and other HIV cure research at IAS 2023

• Guide to other HIV cure-related research at IAS 2023

• Rapporteur summaries: track B clinical science

• Early press conference: cure, gay circumcision, PrEP choices, mpox, and COVID-19

• High rates of occult HBV in Botswana: risks from relying on HBsAg screening

• Anal cancer: 1 in 5 risk of missing precancerous lesions if only HSIL are biopsied

• BHIVA Annual Conference 2023 (BHIVA 2023) – final reports

• No vertical HIV transmissions in the UK from women eligible for supported breastfeeding

• Adverse birth outcomes with diabetes and hypertensive disorders in pregnancy

Antiretrovirals

• CAB-LA receives positive opinion for EU approval as PrEP

Guidelines

• New UK vaccine schedule for HPV depends on HIV status

• UK shingles vaccine: changes from 1 September 2023

• New guidelines on cognitive impairment in people living with HIV

Side effects

• Help needed: UK surveys on access to New-Fill for facial lipoatrophy

HIV prevention and transmission

• Breakthrough HIV infection on PrEP with injectable cabotegravir

• PrEP for women and PrEP: new translations (June 2023)

PDFs

• HTB: no. 7/8 (July/August 2023) PDF download